GF
MRNA icon

Gries Financial’s Moderna MRNA Stock Holding History

Gries Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,700
Closed -$207K – 183
2023
Q2 		$207K Hold
1,700
– – 0.06% 154
2023
Q1 		$261K Sell
1,700
-15
-0.9% -$2.48K 0.08% 149
2022
Q4 		$308K Hold
1,715
– – 0.1% 128
2022
Q3 		$203K Hold
1,715
– – 0.09% 140
2022
Q2 		$245K Hold
1,715
– – 0.12% 112
2022
Q1 		$295K Hold
1,715
– – 0.11% 131
2021
Q4 		$436K Sell
1,715
-200
-10% -$58.5K 0.18% 113
2021
Q3 		$737K Hold
1,915
– – 0.23% 97
2021
Q2 		$802K Buy
1,915
+15
+0.8% +$2.68K 0.26% 86
2021
Q1 		$285K Buy
+1,900
New +$275K 0.09% 141

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Gries Financial's MRNA Position: Q3 2023 in Review

Gries Financial sold out of Moderna (MRNA) in Q3 2023, closing a stake of 1,700 shares — an estimated $207K sold.

Gries Financial first reported a position in MRNA in Q1 2021 and held it in 10 quarters. The position peaked at $802K in Q2 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Gries Financial reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Gries Financial sold 1,700 Moderna shares in Q3 2023, an estimated $207K.
  • Gries Financial first reported a position in Moderna in Q1 2021 and held it in 10 quarters.
  • Gries Financial's Moderna position peaked at $802K in Q2 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Gries Financial's 13F filing for Q3 2023, filed 15 Nov 2023.